Montelukast Sodium
Product Images NDC 42291-621

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Montelukast Sodium (NDC 42291-621). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avkare, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

621 10 Montelukast

AVKARE Montelukast Sodium Tablets 10mg is a prescription medication that is intended for adults aged 15 years and above. The NDC code for this product is 42291-621-10, and it comes in a package of 1000 tablets. The attached patient leaflet for this medication should be dispensed to each patient. The text is a label and does not contain any additional information.*

FDA Label Image

Label 4229162290 Montelukast Sodium 2016 4mg Chewable

This is a description of Avkare Chewable Tablets, the medication containing Montelukast Sodium, meant for pediatric patients aged between 2 to 5 years. The dosage details are mentioned in the circular that accompanies the medicine. The National Drug Code (NDC) for this medicine is 42291-622-90, and it comes with 90 tablets in the pack which is available only with a prescription. The pharmacist should provide the patient leaflet to each patient along with the prescription.*

FDA Label Image

Label 4229162390 Montelukast Sodium 2018 5mg Chewable

FDA Label Image

Montelukast Sodium Tablets And Chewable Tablets 1

This is a graph showing the change in height (in centimeters) over time on different treatments. The treatments compared are Montelukast Sodium 5 mg, Beclomethasone 336 mcg, and Placebo. The graph shows the height measurements over time for each treatment group.*

FDA Label Image

Montelukast Sodium Tablets And Chewable Tablets 2

FDA Label Image

Montelukast Sodium Tablets And Chewable Tablets 3

The text is describing a graph that shows the mean percent change from baseline over 15 weeks of treatment with either placebo or Montelukast Sodium. The x-axis represents the weeks in treatment, ranging from 0 to 15, with a washout period included. The y-axis represents the mean percent change from baseline.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.